IRCT201110087740N1CompletedPhase 3
Intranazal midazolam efficacy in upper endoscopy
Ahvaz University of Medical Sciences and Health Services0 sites105 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 105
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20 years to 60 years (—)
- Sex
- All
Inclusion Criteria
- •Inclusion criterion: patients aged between 20 to 60 years old candidate for upper endoscopy.
- •Exclusion criteria:GIB; COPD; CHF and intolerance to upper endoscopy.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Not yet recruiting
Phase 1
To study the efficacy of Midazolam and its combination with ketamine through the nasal route before transferring children from parent company to the operation theatre, who are scheduled for surgery.CTRI/2020/05/025229Dr Aarti Agarwal
Unknown
Phase 4
Oral Midazolam for Sedation in Esophagogastroduodenoscopy(EGD)Conscious Sedation Failure During ProcedureNCT01990937Phramongkutklao College of Medicine and Hospital260
Completed
Phase 2
Comparative Evaluation of Two Sedatives in Pediatric Dental Procedure - A Randomized Clinical TrialCTRI/2022/02/040572arsinhbhai Patel Dental College and Hospital25
Completed
Not Applicable
Comparing the time required by intramuscular and intranasal forms of Midazolam in aborting seizureCTRI/2020/01/022749Government Medical College and Hospital Aurangabad247
Completed
Phase 2
Premedication With Alprazolam and Midazolam for Upper Gastrointestinal EndoscopyDiagnostic EsophagogastroduodenoscopyNCT03130842Isfahan University of Medical Sciences136